{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:32:00Z","timestamp":1761975120888},"reference-count":37,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Some patients with common variable immunodeficiency (CVID) can generate an antibody response following vaccination with\n            <jats:italic>Neisseria meningitidis<\/jats:italic>\n            polysaccharide, but the duration of this protection is unknown. In this study, serum bactericidal antibody (SBA) responses to serogroup C\n            <jats:italic>N. meningitidis<\/jats:italic>\n            of 23 patients with CVID and 23 sex- and age-matched controls were measured 1 year after vaccination with the plain A\/C meningococcal polysaccharide vaccine. The fold rise in serum bactericidal antibody geometric mean titers of the control group from prevaccination to 1 year postvaccination was significantly higher than that of the patient group (5.41- versus 2.96-fold,\n            <jats:italic>P<\/jats:italic>\n            = 0.009). Of 23 CVID patients, 8 had a poor response to vaccine (&lt;4-fold rise) 3 weeks after vaccination, and low titers remained when measured 1 year later. Of the 15 CVID patients who had a normal response to vaccine (\u22654-fold rise) 3 weeks after vaccination, 6 cases failed to maintain protective SBA titers, whereas the remaining 9 had protective titers 1 year after vaccination. Only one of the 23 controls, who developed protective SBA titers after 3 weeks, lost the protective titers after 1 year. Among the patients, the presence of bronchiectasis and\/or splenomegaly at enrollment was associated with poor SBA response to vaccine at 3 weeks and\/or failure to maintain protective levels at 1 year. The results of this study demonstrate that a number of CVID patients can produce protective antibody titers that can persist for 1 year after vaccination, which lends strong support to the inclusion of polysaccharide vaccine in the immunization program for CVID patients.\n          <\/jats:p>","DOI":"10.1128\/cvi.00389-09","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T02:45:29Z","timestamp":1264646729000},"page":"524-528","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["Serum Bactericidal Antibody Response 1 Year after Meningococcal Polysaccharide Vaccination of Patients with Common Variable Immunodeficiency"],"prefix":"10.1128","volume":"17","author":[{"given":"Nima","family":"Rezaei","sequence":"first","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Moin","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pourpak","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariush","family":"Norouzian","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal Izadi","family":"Mobarakeh","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Aghasadeghi","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nejati","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Read","sequence":"additional","affiliation":[{"name":"Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Pediatrics, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"825","volume":"12","year":"2005","unstructured":"Aghamohammadi, A., A. Farhoudi, M. Moin, N. Rezaei, A. Kouhi, Z. Pourpak, N. Yaseri, M. Movahedi, M. Gharagozlou, F. Zandieh, F. Yazadni, S. Arshi, I. Mohammadzadeh, B. M. Ghazi, M. Mahmoudi, S. Tahaei, and A. Isaeian. 2005. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin. Diagn. Lab. Immunol.12:825-832.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_3_2","first-page":"97","volume":"1","year":"2008","unstructured":"Aghamohammadi, A., V. Lougaris, A. Plebani, T. Miyawaki, A. Durandy, and L. Hammarstr\u00f6m. 2008. Predominantly antibody deficiencies, p. 97-130. In N. Rezaei, A. Aghamohammadi, and L. D. Notarangelo (ed.), Primary immunodeficiency diseases: definition, diagnosis and management,vol. 1. Springer-Verlag, Berlin, Germany.","journal-title":"Primary immunodeficiency diseases: definition, diagnosis and management"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/eci.09.65","volume":"5","year":"2009","unstructured":"Aghamohammadi, A., N. Parvaneh, and N. Rezaei. 2009. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Rev. Clin. Immunol.5:629-631.","journal-title":"Expert Rev. Clin. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10428190500285285","volume":"47","year":"2006","unstructured":"Aghamohammadi, A., N. Parvaneh, F. Tirgari, F. Mahjoob, M. Movahedi, M. Gharagozlou, M. Mansouri, A. Kouhi, N. Rezaei, and D. Webster. 2006. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk. Lymphoma47:343-346.","journal-title":"Leuk. Lymphoma"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1081-1206(10)62149-7","volume":"90","year":"2003","unstructured":"Al-Herz, W., and S. J. McGeady. 2003. Antibody response in common variable immunodeficiency. Ann. Allergy Asthma Immunol.90:244-247.","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"e_1_3_2_7_2","first-page":"780","volume":"10","year":"2003","unstructured":"Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol.10:780-786.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","volume":"23","year":"2005","unstructured":"Borrow, R., P. Balmer, and E. Miller. 2005. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine23:2222-2227.","journal-title":"Vaccine"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1574-695X.2000.tb01460.x","volume":"28","year":"2000","unstructured":"Borrow, R., P. Richmond, E. B. Kaczmarski, A. Iverson, S. L. Martin, J. Findlow, M. Acuna, E. Longworth, R. O'Connor, J. Paul, and E. Miller. 2000. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A\/C polysaccharide vaccine. FEMS Immunol. Med. Microbiol.28:79-85.","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2004.10.048","volume":"115","year":"2005","unstructured":"Carsetti, R., M. M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, A. Meini, A. Plebani, F. Aiuti, and I. Quinti. 2005. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol.115:412-417.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_2_11_2","first-page":"167","volume":"210","year":"1996","unstructured":"Casali, P., and E. W. Schettino. 1996. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol.210:167-179.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_12_2","first-page":"277","volume":"112","year":"2008","unstructured":"Chapel, H., M. Lucas, M. Lee, J. Bjorkander, D. Webster, B. Grimbacher, C. Fieschi, V. Thon, M. R. Abedi, and L. Hammarstrom. 2008. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood112:277-286.","journal-title":"Blood"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0022-3476(86)80927-1","volume":"108","year":"1986","unstructured":"Conley, M. E., C. L. Park, and S. D. Douglas. 1986. Childhood common variable immunodeficiency with autoimmune disease. J. Pediatr.108:915-922.","journal-title":"J. Pediatr."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","volume":"10","year":"1992","unstructured":"Costantino, P., S. Viti, A. Podda, M. A. Velmonte, L. Nencioni, and R. Rappuoli. 1992. Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine10:691-698.","journal-title":"Vaccine"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","year":"1999","unstructured":"Cunningham-Rundles, C., and C. Bodian. 1999. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol.92:34-48.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12026-007-0024-0","volume":"38","year":"2007","unstructured":"Cunningham-Rundles, C., and A. K. Knight. 2007. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol. Res.38:78-86.","journal-title":"Immunol. Res."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","year":"2007","unstructured":"Geha, R. S., L. Notarangelo, J. L. Casanova, H. Chapel, A. Fischer, L. Hammarstrom, S. Nonoyama, H. Ochs, J. Puck, C. Roifman, R. Seger, and J. Wedgwood. 2007. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol.120:776-794.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","volume":"24","year":"2006","unstructured":"Girard, M. P., M. P. Preziosi, M. T. Aguado, and M. P. Kieny. 2006. A review of vaccine research and development: meningococcal disease. Vaccine24:4692-4700.","journal-title":"Vaccine"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","volume":"124","year":"2007","unstructured":"Goldacker, S., R. Draeger, K. Warnatz, D. Huzly, U. Salzer, J. Thiel, et al. 2007. Active vaccination in patients with common variable immunodeficiency (CVID). Clin. Immunol.124:294-303.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0952-7915(00)00098-4","volume":"12","year":"2000","unstructured":"Hayakawa, K., and R. R. Hardy. 2000. Development and function of B-1 cells. Curr. Opin. Immunol.12:346-353.","journal-title":"Curr. Opin. Immunol."},{"key":"e_1_3_2_21_2","first-page":"2049","volume":"72","year":"2005","unstructured":"Kimmel, S. R. 2005. Prevention of meningococcal disease. Am. Fam. Physician72:2049-2056.","journal-title":"Am. Fam. Physician"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2005.03.019","volume":"116","year":"2005","unstructured":"Ko, J., L. Radigan, and C. Cunningham-Rundles. 2005. Immune competence and switched memory B cells in common variable immunodeficiency. Clin. Immunol.116:37-41.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20022020","volume":"197","year":"2003","unstructured":"Kruetzmann, S., M. M. Rosado, H. Weber, U. Germing, O. Tournilhac, H. H. Peter, R. Berner, A. Peters, T. Boehm, A. Plebani, I. Quinti, and R. Carsetti. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med.197:939-945.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.2.156-167.1997"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","volume":"130","year":"2002","unstructured":"Mellemkjaer, L., L. Hammarstrom, V. Andersen, J. Yuen, C. Heilmann, T. Barington, J. Bjorkander, and J. H. Olsen. 2002. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin. Exp. Immunol.130:495-500.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2005.12.1347","volume":"117","year":"2006","unstructured":"Notarangelo, L., J. L. Casanova, M. E. Conley, H. Chapel, A. Fischer, J. Puck, C. Roifman, R. Seger, and R. S. Geha. 2006. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee meeting in Budapest, 2005. J. Allergy Clin. Immunol.117:883-896.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_2_27_2","first-page":"59","volume":"6","year":"2007","unstructured":"Nourizadeh, M., A. Aghamohammadi, S. M. Moazzeni, M. Mahdavi, N. Rezaei, and J. Hadjati. 2007. High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency. Iran J. Allergy Asthma Immunol.6:59-65.","journal-title":"Iran J. Allergy Asthma Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","volume":"23","year":"2003","unstructured":"Piqueras, B., C. Lavenu-Bombled, L. Galicier, F. Bergeron-van der Cruyssen, L. Mouthon, S. Chevret, P. Debre, C. Schmitt, and E. Oksenhendler. 2003. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol.23:385-400.","journal-title":"J. Clin. Immunol."},{"key":"e_1_3_2_29_2","first-page":"169","volume":"7","year":"2008","unstructured":"Ramyar, A., A. Aghamohammadi, K. Moazzami, N. Rezaei, M. Yeganeh, T. Cheraghi, N. Pouladi, G. Heydari, K. Abolhassari, A. A. Amirzargar, N. Parvaneh, and M. Moin. 2008. Presence of idiopathic thrombocytopenia purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency. Iran J. Allergy Asthma Immunol.7:169-175.","journal-title":"Iran J. Allergy Asthma Immunol."},{"key":"e_1_3_2_30_2","first-page":"449","volume":"18","year":"2008","unstructured":"Rezaei, N., A. Aghamohammadi, G. A. Kardar, M. Nourizadeh, and Z. Pourpak. 2008. T- helper 1 and 2 cytokines assay in patients with common variable immunodeficiency. J. Investig. Allergol. Clin. Immunol.18:449-453.","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10875-006-9047-x","volume":"26","year":"2006","unstructured":"Rezaei, N., A. Aghamohammadi, M. Moin, Z. Pourpak, M. Movahedi, M. Gharagozlou, L. Atarod, B. M. Ghazi, A. Isaeian, M. Mahmoudi, K. Abolmaali, D. Mansouri, S. Arshi, N. J. Tarash, R. Sherkat, H. Akbari, R. Amin, A. Alborzi, S. Kashef, R. Farid, I. Mohammadzadeh, M. S. Shabestari, M. Nabavi, and A. Farhoudi. 2006. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J. Clin. Immunol.26:519-532.","journal-title":"J. Clin. Immunol."},{"key":"e_1_3_2_32_2","first-page":"237","volume":"7","year":"2008","unstructured":"Rezaei, N., A. Aghamohammadi, and R. C. Read. 2008. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease. Iran J. Allergy Asthma Immunol.7:237-240.","journal-title":"Iran J. Allergy Asthma Immunol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00489-07"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/j.vaccine.2007.05.021","volume":"25","year":"2007","unstructured":"Rezaei, N., A. Aghamohammadi, S. D. Siadat, M. Nejati, H. Ahmadi, M. Moin, Z. Pourpak, S. Kamali, D. Norouzian, B. Tabaraei, and R. C. Read. 2007. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine25:5308-5314.","journal-title":"Vaccine"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10875-007-9135-6","volume":"28","year":"2008","unstructured":"Rezaei, N., M. Haji-Molla-Hoseini, A. Aghamohammadi, A. A. Pourfathollah, M. Moghtadaie, and Z. Pourpak. 2008. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. J. Clin. Immunol.28:78-84.","journal-title":"J. Clin. Immunol."},{"key":"e_1_3_2_36_2","first-page":"321","volume":"17","year":"2007","unstructured":"Vodjgani, M., A. Aghamohammadi, M. Samadi, M. Moin, J. Hadjati, M. Mirahmadian, N. Parvaneh, A. Salavati, S. Abdollahzade, N. Rezaei, and A. Srrafnejad. 2007. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J. Investig. Allergol. Clin. Immunol.17:321-328.","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","year":"2008","unstructured":"Wehr, C., T. Kivioja, C. Schmitt, B. Ferry, T. Witte, E. Eren, M. Vlkova, M. Hernandez, D. Detkova, P. R. Bos, G. Poerksen, H. von Bernuth, U. Baumann, S. Goldacker, S. Gutenberger, M. Schlesier, F. Bergeron-van der Cruyssen, M. Le Garff, P. Debre, R. Jacobs, J. Jones, E. Bateman, J. Litzman, P. M. van Hagen, A. Plebani, R. E. Schmidt, V. Thon, I. Quinti, T. Espanol, A. D. Webster, H. Chapel, M. Vihinen, E. Oksenhendler, H. H. Peter, and K. Warnatz. 2008. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood111:77-85.","journal-title":"Blood"},{"key":"e_1_3_2_38_2","first-page":"1978","volume":"72","year":"2005","unstructured":"Zimmerman, R. K. 2005. Time of hope for the eventual elimination of meningococcal strains A, C, Y, and W-135 in the United States. Am. Fam. Physician72:1978-1980.","journal-title":"Am. Fam. Physician"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00389-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00389-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:43:36Z","timestamp":1627591416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00389-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1128\/CVI.00389-09"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00389-09","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"2009-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-01-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}